Back

Quercetin reduces APP expression, oxidative stress and mitochondrial dysfunction in the N2a/APPswe cells via ERK1/2 and AKT pathways

Tang, Z.; Guo, M.; Peng, Y.; Xiao, Y.; Zhang, T.; Ni, R.; Qi, X.

2022-09-19 neuroscience
10.1101/2022.09.18.508406 bioRxiv
Show abstract

Abnormal amyloid-{beta} (A{beta}) abnormal accumulation and oxidative stress play important roles in Alzheimers disease (AD). Quercetin has been reported to possess antioxidant and anti-inflammatory properties, and thus of therapeutic interests for neurodegenerative disorders. In the present study, we aimed to characterize the mechanisms by which quercetin exerts neuroprotective effects in murine neuroblastoma N2a cells stably expressing human Swedishh mutant amyloid precursor protein (APP). Quercetin treatment exhibited low cytoxicity, attenuated APP expression and APP-induced oxidative neurotoxicity in N2a/APP cells. We found that quercetin effected via the down-regulation of phospho-extracellular signal{square}regulated protein kinase (p-ERK1/2) pathway and up-regulation of phospho-protein kinase B (p-AKT) pathway in N2a/APP cells. In addition, quercetin ameliorated the elevated levels of reactive oxygen species using DCFH-DA flow-cytometry in N2a/APP cells, lipid peroxidation using (4-HNE), and DNA oxidation (8-OHdG assays). Quercetin ameliorated the loss of mitochondrial membrane potential using JC-1 fluorescence assay in N2a/APP cells in a dose-dependent mannor. In conclusion, we domenstrated the neuroprotective effects of quercetin against the APP expression induced oxidative neurotoxicity, impairment of mitochondrial function and oxidative stress through inactivation of the ERK1/2 signaling pathway and activation of AKT signaling pathways.

Matching journals

The top 13 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 17%
10.8%
2
Brain Research
38 papers in training set
Top 0.1%
5.6%
3
International Journal of Molecular Sciences
494 papers in training set
Top 1%
5.6%
4
eLife
5828 papers in training set
Top 33%
3.3%
5
Frontiers in Pharmacology
111 papers in training set
Top 0.7%
3.3%
6
Molecular Neurobiology
53 papers in training set
Top 0.3%
3.3%
7
Frontiers in Aging Neuroscience
74 papers in training set
Top 0.4%
3.2%
8
Heliyon
152 papers in training set
Top 1%
3.2%
9
Antioxidants
25 papers in training set
Top 0.2%
2.8%
10
Scientific Reports
3612 papers in training set
Top 37%
2.8%
11
Molecular and Cellular Neuroscience
20 papers in training set
Top 0.1%
2.4%
12
Cells
249 papers in training set
Top 2%
2.4%
13
Biomolecules
100 papers in training set
Top 1%
1.7%
50% of probability mass above
14
Free Radical Biology and Medicine
36 papers in training set
Top 0.4%
1.5%
15
Acta Biochimica et Biophysica Sinica
23 papers in training set
Top 0.3%
1.5%
16
Journal of Alzheimer’s Disease
50 papers in training set
Top 0.9%
1.5%
17
Neurochemistry International
10 papers in training set
Top 0.1%
1.5%
18
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
26 papers in training set
Top 0.4%
1.4%
19
Neuroscience Bulletin
12 papers in training set
Top 0.1%
1.4%
20
Molecules
39 papers in training set
Top 0.9%
1.1%
21
Life Sciences
27 papers in training set
Top 0.8%
1.1%
22
Cell Death & Disease
126 papers in training set
Top 2%
1.1%
23
ACS Chemical Neuroscience
67 papers in training set
Top 1.0%
1.1%
24
Biomedicine & Pharmacotherapy
42 papers in training set
Top 0.9%
1.1%
25
Journal of Biomolecular Structure and Dynamics
43 papers in training set
Top 0.8%
1.1%
26
Redox Biology
70 papers in training set
Top 0.9%
1.1%
27
Bioscience Reports
27 papers in training set
Top 1%
1.0%
28
Molecular Biology Reports
21 papers in training set
Top 0.7%
1.0%
29
iScience
1154 papers in training set
Top 33%
0.9%
30
Frontiers in Neuroscience
256 papers in training set
Top 6%
0.9%